GlassScriptPhysician profile
Anthony J Wright
NPI 1265523518
$12,627.65
in general payments reported to CMS, 2019-2025
34 companies · $265 in 2025
The $265 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,353 · 2020: $155 · 2021: $389 · 2022: $364 · 2023: $2,627 · 2024: $2,475 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,458 · Food and Beverage: $2,422 · Education: $461 · Gift: $24.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,458.27 |
| Food and Beverage | $2,422.16 |
| Education | $460.68 |
| Gift | $24.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,264.78 | 2019-2024 | Da Vinci Surgical System |
| Medshape, INC. | $403.00 | 2023 | Dynanail |
| Davol INC. | $214.14 | 2020-2021 | |
| Kerecis Limited | $198.92 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $171.30 | 2019-2025 | Collagenase Santyl, Stravix, Oasis |
| Vertex Pharmaceuticals Incorporated | $155.83 | 2025 | |
| Medtronic, INC. | $127.82 | 2021-2025 | Progrip, Corevalve Evolut R, Endo Clip III |
| Ethicon US, LLC | $106.75 | 2019-2023 | Vistaseal |
| Endo Pharmaceuticals INC. | $104.09 | 2019-2020 | |
| Asensus Surgical, INC. | $94.59 | 2019-2022 | |
| Standard Bariatrics, INC. | $73.24 | 2022 | |
| Hologic Sales and Service, LLC | $66.84 | 2023-2025 | Coolseal Generator, Trunode |
| Organogenesis INC. | $60.41 | 2023 | Puraply |
| Pacira Pharmaceuticals Incorporated | $48.19 | 2022-2023 | Exparel |
| Focal Therapeutics, INC. | $46.12 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $44.60 | 2022 | |
| Acell, INC. | $44.00 | 2019 | |
| Access Pro Medical, LLC | $42.38 | 2023 | Matriderm |
| Lsi Solutions INC | $38.77 | 2023 | Running Device, Ti Knot |
| Conmed Corporation | $30.56 | 2022-2023 | Airseal |
| Takeda Pharmaceuticals U.S.A., INC. | $28.22 | 2021 | |
| Merck Sharp & Dohme LLC | $26.60 | 2019 | |
| Cardinal Health 414 LLC | $25.85 | 2019 | |
| Olympus America INC. | $24.45 | 2019 | |
| Alexion Pharmaceuticals, INC. | $24.27 | 2021 | |
| Innocoll Pharmaceuticals Limited | $20.82 | 2021 | |
| Avanos Medical | $20.72 | 2019 | |
| Novo Nordisk INC | $19.90 | 2023 | Wegovy |
| Teleflex LLC | $19.38 | 2025 | Titan Sgs Bailout Chuck |
| Covidien LP | $17.59 | 2020 | |
| Cgg Medical INC | $17.49 | 2024 | |
| Merit Medical Systems INC | $15.96 | 2021 | |
| Shire North American Group INC | $15.45 | 2019 | |
| Integra Lifesciences Corporation | $14.62 | 2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.